ロード中...
Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies
Maintaining bone health remains a clinical challenge in patients with prostate cancer (PC) who are at risk of developing metastatic bone disease and increased bone loss due to hormone ablation therapy. In patients with cancer-treatment induced bone loss (CTIBL), antiresorptive agents have been shown...
保存先:
| 出版年: | Int J Endocrinol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4329828/ https://ncbi.nlm.nih.gov/pubmed/25802521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/838202 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|